Find a Tender · Contract
Workflow for NHS Lab delivering SCID Evaluation
A public procurement published by NHS England via Find a Tender.
- —
- Award value
- —
- Tender value
- 2
- Suppliers
- 2
- Awards
- 3
- Notices
- Contract
- Stage
Overview
This is a contract for a Lab delivering a service for the ministerially approved Severe Combined Immunodeficiency (SCID) in-service evaluation. This is for the evaluation of the SCID Assay. This contract will expire 30th September 2025.
Key details
- Buyer
- NHS England
- Source
- Find a Tender
- Lifecycle stage
- Contract
- Status
- complete
- CPV classification
- 85111810 — Blood analysis services
- Currency
- GBP
- Total award value
- —
- Tender value
- —
- First published
- 1 Mar 2024
- Last updated
- 25 Nov 2025
Awards
2 awards recorded on this procurement.
| Supplier | Companies House | Awarded | Status | Value |
|---|---|---|---|---|
| THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST | — | — | active | — |
| CH&CO Catering Limited, Trading as Pabulum | — | — | active | — |
Notice timeline
Every published notice in this procurement's lifecycle.
All suppliers
Frameworks & programmes
More from NHS England
FAQs about this procurement
Who is the buyer for "Workflow for NHS Lab delivering SCID Evaluation"?
Workflow for NHS Lab delivering SCID Evaluation is a UK public-sector procurement published by NHS England via Find a Tender.
Has "Workflow for NHS Lab delivering SCID Evaluation" been awarded?
Yes — 2 awards are recorded. The current lifecycle stage is "Contract".
Which suppliers are involved in "Workflow for NHS Lab delivering SCID Evaluation"?
2 suppliers are linked: THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST, CH&CO Catering Limited, Trading as Pabulum.
When was "Workflow for NHS Lab delivering SCID Evaluation" published?
It was first published on 1 Mar 2024 and last updated on 25 Nov 2025, across 3 notices.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable